The disclosure provides methods for treating, controlling or mitigatingleukopenia (e.g. neutropenia) and/or thrombocytopenia, for example in thecontext of cancerchemotherapy, comprising administration of a monoacetyl-diacyl-glycerolcompound, as wellas compositions useful therefor.